Momordica charantia Extract
- Generic Name
- Momordica charantia Extract
Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency
Phase 2
Completed
- Conditions
- Uncomplicated Plasmodium Falciparum
- Interventions
- First Posted Date
- 2023-04-25
- Last Posted Date
- 2023-05-16
- Lead Sponsor
- Syamsudin Abdillah,Ph.D, Pharm D
- Target Recruit Count
- 36
- Registration Number
- NCT05829187
- Locations
- 🇮🇩
Kori Puskesmas, Tambolaka, East Nusa Tenggara, Indonesia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath